Skip to main content
. 2021 Aug 8;40(12):1579–1588. doi: 10.1016/j.healun.2021.07.026

Figure 2.

Figure 2

Development of local and systemic adverse events after each SARS-CoV-2 messenger RNA vaccine dose among heart and lung transplant recipients. Percent of participants reporting adverse events within 7 day of receipt of doses 1 and 2 by symptom severity.